Jame Abraham

7PUBLICATIONS
55CO-AUTHORS
Tumour immunologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 26, 2023
Phase II Clinical Trial of Pembrolizumab and Chemotherapy Reveals Distinct Transcriptomic Profiles by Radiologic Response in Metastatic Triple-Negative Breast Cancer.

Avia D Wilkerson, Prerana Bangalore Parthasarathy, Nickolas Stabellini

|Jun 21, 2022
Novel Radiomic Measurements of Tumor-Associated Vasculature Morphology on Clinical Imaging as a Biomarker of Treatment Response in Multiple Cancers.

Nathaniel Braman, Prateek Prasanna, Kaustav Bera

|Jul 29, 2020
Novel HER2-targeted therapies for HER2-positive metastatic breast cancer.

Siddharth Kunte, Jame Abraham, Alberto J Montero

Pageof 2